[{"id":"d4627bcf-9ab8-454b-a033-848eb947a528","acronym":"","url":"https://clinicaltrials.gov/study/NCT00517049","created_at":"2021-01-18T01:52:01.088Z","updated_at":"2024-07-02T16:37:21.391Z","phase":"Phase 2","brief_title":"A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)","source_id_and_acronym":"NCT00517049","lead_sponsor":"Genentech, Inc.","biomarkers":" CD20","pipe":" | ","alterations":" CD20 positive","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Rituxan (rituximab) • drozitumab (RG7425)"],"overall_status":"Completed","enrollment":" Enrollment 49","initiation":"Initiation: 03/01/2008","start_date":" 03/01/2008","primary_txt":" Primary completion: 12/01/2009","primary_completion_date":" 12/01/2009","study_txt":" Completion: 12/01/2009","study_completion_date":" 12/01/2009","last_update_posted":"2017-06-06"}]